Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Low-risk penicillin allergy delabeling through a direct oral challenge in immunocompromised and/or multiple drug allergy labeled patients in a critical care setting.
Koo G, Stollings JL, Lindsell C, Dear ML, Kripalani S, Nelson GE, McCoy AB, Rice TW, Phillips EJ, Stone CA Jr; Vanderbilt University Medical Center Learning Healthcare System. Koo G, et al. Among authors: stollings jl. J Allergy Clin Immunol Pract. 2022 Jun;10(6):1660-1663.e2. doi: 10.1016/j.jaip.2022.01.041. Epub 2022 Feb 5. J Allergy Clin Immunol Pract. 2022. PMID: 35131513 Free PMC article. No abstract available.
Risk-stratified management to remove low-risk penicillin allergy labels in the patients with COVID-19 in the intensive care unit.
Stollings JL, Koo G, Lindsell CJ, Dear ML, McCoy A, Rice TW, Phillips EJ, Stone CA Jr; Vanderbilt Learning Healthcare System Investigators. Stollings JL, et al. J Allergy Clin Immunol Pract. 2023 Feb;11(2):632-635. doi: 10.1016/j.jaip.2022.08.043. Epub 2022 Sep 11. J Allergy Clin Immunol Pract. 2023. PMID: 36100133 Free PMC article. No abstract available.
Risk-stratified Management to Remove Low-Risk Penicillin Allergy Labels in the ICU.
Stone CA Jr, Stollings JL, Lindsell CJ, Dear ML, Buie RB, Rice TW, Phillips EJ. Stone CA Jr, et al. Among authors: stollings jl. Am J Respir Crit Care Med. 2020 Jun 15;201(12):1572-1575. doi: 10.1164/rccm.202001-0089LE. Am J Respir Crit Care Med. 2020. PMID: 32083961 Free PMC article. No abstract available.
Cefepime vs Piperacillin-Tazobactam in Adults Hospitalized With Acute Infection: The ACORN Randomized Clinical Trial.
Qian ET, Casey JD, Wright A, Wang L, Shotwell MS, Siemann JK, Dear ML, Stollings JL, Lloyd BD, Marvi TK, Seitz KP, Nelson GE, Wright PW, Siew ED, Dennis BM, Wrenn JO, Andereck JW, Han JH, Self WH, Semler MW, Rice TW; Vanderbilt Center for Learning Healthcare and the Pragmatic Critical Care Research Group. Qian ET, et al. Among authors: stollings jl. JAMA. 2023 Oct 24;330(16):1557-1567. doi: 10.1001/jama.2023.20583. JAMA. 2023. PMID: 37837651 Free PMC article.
Protocol and statistical analysis plan for the Antibiotic Choice On ReNal outcomes (ACORN) randomised clinical trial.
Qian ET, Casey JD, Wright A, Wang L, Siemann J, Dear ML, Stollings J, Lloyd BD, Seitz K, Nelson G, Wright P, Siew ED, Dennis B, Wrenn J, Andereck J, Self WH, Semler MW, Rice TW; Vanderbilt Learning Healthcare System Platform Investigators. Qian ET, et al. BMJ Open. 2023 Mar 10;13(3):e066995. doi: 10.1136/bmjopen-2022-066995. BMJ Open. 2023. PMID: 36898748 Free PMC article.
Protocol and Statistical Analysis Plan for the Mode of Ventilation During Critical Illness (MODE) Trial.
Seitz KP, Lloyd BD, Wang L, Shotwell MS, Qian ET, Richardson RK, Rooks JC, Hennings-Williams V, Sandoval CE, Richardson WD, Morgan T, Thompson AN, Hastings PG, Ring TP, Stollings JL, Talbot EM, Krasinski DJ, Decoursey B, Gibbs KW, Self WH, Mixon AS, Rice TW, Semler MW, Casey JD. Seitz KP, et al. Among authors: stollings jl. CHEST Crit Care. 2024 Mar;2(1):100033. doi: 10.1016/j.chstcc.2023.100033. Epub 2023 Nov 25. CHEST Crit Care. 2024. PMID: 38742219 Free PMC article.
Long-term outcomes after treatment of delirium during critical illness with antipsychotics (MIND-USA): a randomised, placebo-controlled, phase 3 trial.
Mart MF, Boehm LM, Kiehl AL, Gong MN, Malhotra A, Owens RL, Khan BA, Pisani MA, Schmidt GA, Hite RD, Exline MC, Carson SS, Hough CL, Rock P, Douglas IS, Feinstein DJ, Hyzy RC, Schweickert WD, Bowton DL, Masica A, Orun OM, Raman R, Pun BT, Strength C, Rolfsen ML, Pandharipande PP, Brummel NE, Hughes CG, Patel MB, Stollings JL, Ely EW, Jackson JC, Girard TD. Mart MF, et al. Among authors: stollings jl. Lancet Respir Med. 2024 Aug;12(8):599-607. doi: 10.1016/S2213-2600(24)00077-8. Epub 2024 Apr 30. Lancet Respir Med. 2024. PMID: 38701817 Clinical Trial.
105 results